Preclinical efficacy of hK2 targeted [¹⁷⁷Lu]hu11B6 for prostate cancer theranostics.

ABSTRACT:

SUBMITTER: Timmermand OV 

PROVIDER: S-EPMC6531309 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature